title: Modulation of differentiation markers in human choriocarcinoma cells by extracellular matrix: on the role of a three-dimensional matrix structure.
abstract: During spontaneous or chemically induced differentiation human choriocarcinoma cells express typical characteristics of the normal differentiating trophoblast: 1) increased production of peptide and steroid hormones (chorionic gonadotropin, placental lactogen, estrogens, progesterone); 2) increased activity of cellular alkaline phosphatase; 3) morphological transition from cytotrophoblast to syncytiotrophoblast-like cells; and 4) arrested cell proliferation. Since the extracellular matrix is known to control gene expression we have examined the effects of different substrates composed of matrix macromolecules on the differentiation of BeWo choriocarcinoma cells. Matrices tested were: fibronectin, laminin, collagens type I and type IV, the basement membrane-like complex matrix Matrigel, and a complex matrix extracted from human term placenta. Irrespective of the type of molecule(s), it was consistently found that, whenever the matrix molecules were presented as three-dimensional structures (as opposed to protein coatings on tissue culture plastic) the response of affected differentiation markers monitored was highly pronounced. Morphology was changed from monolayers to rounded colonies, cell proliferation was reduced, and the secretion of chorionic gonadotropin was increased up to tenfold. Heterogeneous effects were observed on progesterone secretion and on the activity of cellular alkaline phosphatase. Cell adhesion to matrix molecules, however, did not depend on the structure of the matrix. This study demonstrates that gene expression in these tumor cells can be modified by extracellular matrix and highlights that not only the presence of effector molecules in the matrix but also the three-dimensional structure of the matrix is important for the induction of differentiation.
authors.affiliation: Department of Biochemistry, University of Alabama, Birmingham 35294.
authors.forename: H P
authors.initials: HP
authors.lastname: Hohn
authors.forename: C R
authors.initials: CR
authors.lastname: Parker
authors.forename: L R
authors.initials: LR
authors.lastname: Boots
authors.forename: H W
authors.initials: HW
authors.lastname: Denker
authors.forename: M
authors.initials: M
authors.lastname: Höök
mesh_terms: D000469:Alkaline Phosphatase / Q000378:metabolism; D002448:Cell Adhesion; D002454:Cell Differentiation / Q000502:physiology*; D002455:Cell Division; D002822:Choriocarcinoma; D006063:Chorionic Gonadotropin / Q000378:metabolism; D004273:DNA, Neoplasm / Q000096:biosynthesis; D005109:Extracellular Matrix / Q000502:physiology* / Q000648:ultrastructure; D005260:Female; D006801:Humans; D007700:Kinetics; D008715:Methionine / Q000378:metabolism; D009363:Neoplasm Proteins / Q000378:metabolism; D011247:Pregnancy; D011374:Progesterone / Q000378:metabolism; D013936:Thymidine / Q000378:metabolism; D014407:Tumor Cells, Cultured; D014594:Uterine Neoplasms
chemical_list: D006063:Chorionic Gonadotropin; D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D011374:Progesterone; D008715:Methionine; D000469:Alkaline Phosphatase; D013936:Thymidine